By Onyx Bugett | TalkLife News
South Korea is preparing to approve medication used to end early pregnancies for the first time, creating a regulated option years after the country’s Constitutional Court ordered the decriminalization of abortion.
The government plans to authorize mifepristone and misoprostol for pregnancies of up to nine weeks beginning in early 2027. During the program’s first two years, doctors would both prescribe and dispense the medication.
From court ruling to practical access
South Korea’s Constitutional Court ruled in 2019 that the country’s abortion ban was unconstitutional. Decriminalization, however, did not automatically establish a complete regulatory and health-care system for medication abortion.
The new proposal is intended to create a formal route for prescribing, distributing and monitoring the medication. Medical organizations and advocates will be watching details involving training, cost, privacy and access outside major cities.
What is confirmed
The government’s plan is confirmed, but the medication is not yet available under the proposed program. Final implementation rules could change before the expected 2027 launch.
Mifepristone and misoprostol are different medications used in sequence. Reporting should distinguish regulatory approval from immediate availability and should not substitute general information for advice from a qualified medical professional.
Source: Associated Press, September 17, 2026.
Image credit: Rod of Asclepius medical symbol via Wikimedia Commons. Reuse terms listed with the original media record. Used as an illustration, not as event photography.